Semantic Scholar uses AI to extract papers important to this topic.
Sodium-glucose cotransporter 2 (SGLT2) inhibitors improve glycaemia in patients with type 2 diabetes by enhancing… Expand BACKGROUND
Addition of a sulphonylurea to metformin improves glycaemic control in type 2 diabetes, but is associated with… Expand Aims: Progressive deterioration of glycaemic control in type 2 diabetes mellitus (T2DM) often requires treatment intensification… Expand BACKGROUND
New treatments for type 2 diabetes mellitus are needed to retain insulin-glucose coupling and lower the risk of weight… Expand OBJECTIVE—The efficacy and safety of adding liraglutide (a glucagon-like peptide-1 receptor agonist) to metformin were compared… Expand Aim: To examine the efficacy and safety of vildagliptin vs. glimepiride as add‐on therapy to metformin in patients with type 2… Expand CONTEXT
No antidiabetic regimen has demonstrated the ability to reduce progression of coronary atherosclerosis. Commonly used… Expand Aim: To assess the efficacy and safety of a 24‐week treatment with sitagliptin, a highly selective once‐daily oral dipeptidyl… Expand CONTEXT
Carotid artery intima-media thickness (CIMT) is a marker of coronary atherosclerosis and independently predicts… Expand The importance of strict glycemic control to limit the risk of diabetic vascular complications is indisputable, but many barriers… Expand